These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 33793560)
21. An outbreak of Kyasanur forest disease in the Wayanad and Malappuram districts of Kerala, India. Sadanandane C; Elango A; Marja N; Sasidharan PV; Raju KHK; Jambulingam P Ticks Tick Borne Dis; 2017 Jan; 8(1):25-30. PubMed ID: 27692988 [TBL] [Abstract][Full Text] [Related]
22. Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiata. Patil DR; Yadav PD; Shete A; Chaubal G; Mohandas S; Sahay RR; Jain R; Mote C; Kumar S; Kaushal H; Kore P; Patil S; Majumdar T; Fulari S; Suryawanshi A; Kadam M; Pardeshi PG; Lakra R; Sarkale P; Mourya DT Sci Rep; 2020 Jul; 10(1):12561. PubMed ID: 32724103 [TBL] [Abstract][Full Text] [Related]
23. Identification of bio-climatic determinants and potential risk areas for Kyasanur forest disease in Southern India using MaxEnt modelling approach. Pramanik M; Singh P; Dhiman RC BMC Infect Dis; 2021 Dec; 21(1):1226. PubMed ID: 34876036 [TBL] [Abstract][Full Text] [Related]
24. Forest loss shapes the landscape suitability of Kyasanur Forest disease in the biodiversity hotspots of the Western Ghats, India. Walsh MG; Mor SM; Maity H; Hossain S Int J Epidemiol; 2019 Dec; 48(6):1804-1814. PubMed ID: 31740967 [TBL] [Abstract][Full Text] [Related]
25. 'None of my ancestors ever discussed this disease before!' How disease information shapes adaptive capacity of marginalised rural populations in India. Asaaga FA; Rahman M; Kalegowda SD; Mathapati J; Savanur I; Srinivas PN; Seshadri T; Narayanswamy D; Kiran SK; Oommen MA; Young JC; Purse BV PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009265. PubMed ID: 33705400 [TBL] [Abstract][Full Text] [Related]
26. Characterization of host receptor interaction with envelop protein of Kyasanur forest disease virus and predicting suitable epitopes for vaccine candidate. Dey S; Pratibha M; Singh Dagur H; Rajakumara E J Biomol Struct Dyn; 2024 May; 42(8):4110-4120. PubMed ID: 37272880 [TBL] [Abstract][Full Text] [Related]
27. Kyasanur forest disease: a state-of-the-art review. Gupta N; Wilson W; Neumayr A; Saravu K QJM; 2022 Jun; 115(6):351-358. PubMed ID: 33196834 [TBL] [Abstract][Full Text] [Related]
28. Kyasanur Forest Disease, is our surveillance system healthy to prevent a larger outbreak? A mixed-method study, Shivamogga, Karnataka, India: 2019. Bhat P; S JH; Raju MK; Sooda S; K P; Kumar R Int J Infect Dis; 2021 Oct; 110 Suppl 1():S50-S61. PubMed ID: 34416404 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of ixodid ticks on goats and risk factors for tick-borne diseases in humans in the Kyasanur forest disease endemic area of Kerala, India. Sahina S; Sithalakshmi S; Balasubramanian R Parasitol Res; 2024 Feb; 123(2):131. PubMed ID: 38353765 [TBL] [Abstract][Full Text] [Related]
30. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019. Munivenkatappa A; Yadav PD; Sahay RR; Sk K; Shete AM; Patil DY; Mohandas S; Jain R; Patil S; Sinha DP; Jayaswamy MM Infect Dis (Lond); 2024 Feb; 56(2):145-156. PubMed ID: 37966909 [TBL] [Abstract][Full Text] [Related]
32. Bioinformatics characterization of envelope glycoprotein from Kyasanur Forest disease virus. Shil P; Yadav PD; Patil AA; Balasubramanian R; Mourya DT Indian J Med Res; 2018 Feb; 147(2):195-201. PubMed ID: 29806609 [TBL] [Abstract][Full Text] [Related]
33. Occupational exposure of cashew nut workers to Kyasanur Forest disease in Goa, India. Patil DY; Yadav PD; Shete AM; Nuchina J; Meti R; Bhattad D; Someshwar S; Mourya DT Int J Infect Dis; 2017 Aug; 61():67-69. PubMed ID: 28627428 [TBL] [Abstract][Full Text] [Related]
34. Comparative pathogenesis of Alkhumra hemorrhagic fever and Kyasanur forest disease viruses in a mouse model. Sawatsky B; McAuley AJ; Holbrook MR; Bente DA PLoS Negl Trop Dis; 2014 Jun; 8(6):e2934. PubMed ID: 24922308 [TBL] [Abstract][Full Text] [Related]
35. Cellular Immune Responses Against γ-Inactivated Antigen in the Recovered Cases of Kyasanur Forest Disease. Kaushal H; Kartaskar RS; Chiplunkar T; Yadav PD; Awate P; Potdar VA; Khalipe MM; Saraf C; Shete AM; Sahay RR; Das S; Chandrakant SA; Alagarasu K Viral Immunol; 2024 Mar; 37(2):101-106. PubMed ID: 38315741 [TBL] [Abstract][Full Text] [Related]
36. Preliminary risk maps for transmission of kyasanur forest disease in Southern India. Peterson AT; Talukdar G Indian J Public Health; 2017; 61(1):47-50. PubMed ID: 28218163 [TBL] [Abstract][Full Text] [Related]
37. Retrospective Study of Kyasanur Forest Disease and Deaths among Nonhuman Primates, India, 1957-2020. Chakraborty S; Sander WE; Allan BF; Andrade FCD Emerg Infect Dis; 2021 Jul; 27(7):1969-1973. PubMed ID: 34152964 [TBL] [Abstract][Full Text] [Related]
38. Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture. Cook BW; Ranadheera C; Nikiforuk AM; Cutts TA; Kobasa D; Court DA; Theriault SS PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004871. PubMed ID: 27479197 [TBL] [Abstract][Full Text] [Related]
39. Cross-species pathogen spillover across ecosystem boundaries: mechanisms and theory. Borremans B; Faust C; Manlove KR; Sokolow SH; Lloyd-Smith JO Philos Trans R Soc Lond B Biol Sci; 2019 Sep; 374(1782):20180344. PubMed ID: 31401953 [TBL] [Abstract][Full Text] [Related]
40. The epizootics of Kyasanur Forest disease in wild monkeys during 1964 to 1973. Sreenivasan MA; Bhat HR; Rajagopalan PK Trans R Soc Trop Med Hyg; 1986; 80(5):810-4. PubMed ID: 3603621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]